Translate page

  • Presentations from the EHA2022 Congress

  • EHA 2022: Mechanisms of disease progression in chronic myeloid leukemia (S. Tiong Ong)

  • EHA 2022: Non-BCR-ABL1 biomarkers of prognosis in CML (Shady Awad)

  • COLT Meeting 2019: CML related topics

  • COLT Meeting 2019: The CML frontier

    iCMLf Forum 2013: Webstreams now availableiCMLf Forum 2013_Speaker

    Webstreams of the presentations of the 2013 iCMLf Forum are now available to view.

    1) Implementation of Quantitative PCR of p210 BCR-ABL fusion transcript for CML patients at Valdivia Hospital, Chile

    2) Overcoming challenges treating CML: Best practice from Ghana

    3) China standardisation project of BCR-ABL detection in CML - an efficient way for multi-centres to simultaneously derive and validate conversion factors

    The webstreams are available as audio plus slides only, so please click on the presentation below and turn up your loudspeakers!
    (We are very grateful for the support of Brandcast media to produce these web streams)

     

    Implementation of Quantitative PCR  of p210 BCR-ABL fusion transcript for Chronic Myeloid Leukemia patients at Valdivia Hospital, Chile

     

    DSC00677-001

     

    Dr. Lilian Pilleux
    Valdivia Hospital
    Universidad Austral de Chile
    Valdivia, Chile

     

     

     

    Overcoming Challenges Treating CML: Best Practice From Ghana

    DSC00668-001

     

    DR. AMMA ANIMA BENNEH

    Department of Haematology
    Korle-Bu Teaching Hospital
    Accra, Ghana

     

    China Standardization Project of BCR-ABL detection in CML - an efficient way for multi-centers to simultaneously derive and validate Conversion Factors 

     DSC00670-001

     

    Xiao-Jun Huang
    Peking University People's Hospital,  Peking University Institute of Hematology,
    Beijing, China